Kasi, A., Chidharla, A., Al-Rajabi, R. M. T., Bradbury, S., Phadnis, M. A., Clark, L., Huang, C. H., Doolittle, G. C., Neupane, P. C., Mathew, N. S., Wulff, E., Li, H., Abbasi, S., Baranda, J. C., Sun, W., Parikh, R. A. (2026). A late-phase randomized open-label multi-cohort trial to evaluate immune-related adverse events with different standard-of-care dosing strategies of standard-of-care immunotherapies: ImmuRAd trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps12172